Literature DB >> 10560332

Evaluation of 18F-FDG positron emission tomography in gastric and oesophageal carcinoma.

D McAteer1, F Wallis, G Couper, M Norton, A Welch, D Bruce, K Park, M Nicolson, F J Gilbert, P Sharp.   

Abstract

The aim of this study was to evaluate 18F-fluoro-deoxyglucose (FDG) positron emission tomography (PET) in gastric and oesophageal carcinoma. 16 patients with biopsy proven oesophageal or gastric carcinoma had PET scans. Four patients had advanced disease and received palliative treatment. The remaining 12 patients were randomized to immediate surgery or neoadjuvant chemotherapy. Three patients had repeat PET scans following chemotherapy. PET detected the primary tumour in all cases including stage T1 lesions. Involved locoregional nodes (N1, N2) were not identified separately from the primary tumour. Semiquantitative analysis was performed in the form of tumour to liver activity ratios (TLR). In general, the TLR values were higher in the higher T stages, although there was only one case each of T1 and T2 lesions. PET scanning using 18F-FDG is a sensitive method for detecting primary oesophageal and gastric cancers but is limited in locoregional staging.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10560332     DOI: 10.1259/bjr.72.858.10560332

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  16 in total

1.  Detection of response to neoadjuvant therapy of esophageal squamous cell carcinoma by positron emission tomography (PET).

Authors:  G W Couper; K G M Park
Journal:  Ann Surg       Date:  2003-02       Impact factor: 12.969

2.  Significant clinical impact and prognostic stratification provided by FDG-PET in the staging of oesophageal cancer.

Authors:  Cuong P Duong; Helen Demitriou; Leann Weih; Anne Thompson; David Williams; Robert J S Thomas; Rodney J Hicks
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-02-10       Impact factor: 9.236

3.  Laparoscopy, computerised tomography and fluorodeoxyglucose positron emission tomography in the management of gastric and gastro-oesophageal junction cancers.

Authors:  A Mirza; S Galloway
Journal:  Surg Endosc       Date:  2015-10-20       Impact factor: 4.584

4.  2-deoxy-2-[F-18]fluoro-D-glucose-positron emission tomography/computed tomography imaging evaluation of esophageal cancer.

Authors:  Hossein Jadvar; Robert W Henderson; Peter S Conti
Journal:  Mol Imaging Biol       Date:  2006 May-Jun       Impact factor: 3.488

5.  Neoadjuvant therapy of esophageal squamous cell carcinoma: response evaluation by positron emission tomography.

Authors:  B L Brücher; W Weber; M Bauer; U Fink; N Avril; H J Stein; M Werner; F Zimmerman; J R Siewert; M Schwaiger
Journal:  Ann Surg       Date:  2001-03       Impact factor: 12.969

6.  Adenocarcinoma of the esophagus and the esophagogastric junction: positron emission tomography improves staging and prediction of survival in distant but not in locoregional disease.

Authors:  Eero I T Sihvo; Jari V Räsänen; M Juhani Knuuti; Heikki R I Minn; Markku E S Luostarinen; Tapio Viljanen; Martti A Färkkilä; Jarmo A Salo
Journal:  J Gastrointest Surg       Date:  2004-12       Impact factor: 3.452

7.  Assessment of lymph node metastases using 18F-FDG PET in patients with advanced gastric cancer.

Authors:  Seok-Ki Kim; Keon Wook Kang; Jong Seok Lee; Hark Kyun Kim; Hee Jin Chang; Jin Yi Choi; Jun Ho Lee; Keun Won Ryu; Young-Woo Kim; Jae-Moon Bae
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-10-15       Impact factor: 9.236

8.  Fluorodeoxyglucose-positron emission tomography in adenocarcinomas of the distal esophagus and cardia.

Authors:  Katja Ott; Wolfgang A Weber; Ulrich Fink; Hermann Helmberger; Karen Becker; Hubert J Stein; James Müller; Markus Schwaiger; Jörg Rüdiger Siewert
Journal:  World J Surg       Date:  2003-08-18       Impact factor: 3.352

9.  Evaluation of 18F-2-deoxy-2-fluoro-D-glucose positron emission tomography for gastric cancer.

Authors:  Erito Mochiki; Hiroyuki Kuwano; Hiroyuki Katoh; Takayuki Asao; Noboru Oriuchi; Keigo Endo
Journal:  World J Surg       Date:  2004-02-17       Impact factor: 3.352

10.  FDG-PET status following chemoradiotherapy provides high management impact and powerful prognostic stratification in oesophageal cancer.

Authors:  Cuong P Duong; Rodney J Hicks; Leann Weih; Elizabeth Drummond; Trevor Leong; Michael Michael; Robert J S Thomas
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-03-21       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.